Intervention Review

Surgical excision margins for primary cutaneous melanoma

  1. Michael J Sladden1,*,
  2. Charles Balch2,
  3. David A Barzilai3,
  4. Daniel Berg4,
  5. Anatoli Freiman5,
  6. Teenah Handiside6,
  7. Sally Hollis6,
  8. Marko B Lens7,
  9. John F Thompson8

Editorial Group: Cochrane Skin Group

Published Online: 7 OCT 2009

Assessed as up-to-date: 2 AUG 2009

DOI: 10.1002/14651858.CD004835.pub2


How to Cite

Sladden MJ, Balch C, Barzilai DA, Berg D, Freiman A, Handiside T, Hollis S, Lens MB, Thompson JF. Surgical excision margins for primary cutaneous melanoma. Cochrane Database of Systematic Reviews 2009, Issue 4. Art. No.: CD004835. DOI: 10.1002/14651858.CD004835.pub2.

Author Information

  1. 1

    University of Tasmania, Department of Medicine, Launceston, Tasmania, Australia

  2. 2

    Johns Hopkins Medical Institutions, Surgery, Baltimore, Maryland, USA

  3. 3

    Case Western Reserve University, Cleveland, USA

  4. 4

    University of Washington Medical Center, Department of Medicine/Dermatology, Seattle, Washington, USA

  5. 5

    University of Toronto, Division of Dermatology, Toronto, ON, Canada

  6. 6

    University of Nottingham, c/o Cochrane Skin Group, Nottingham, UK

  7. 7

    King's College, Genetic Epidemiology Unit, London, UK

  8. 8

    University of Sydney, The Sydney Melanoma Unit, Sydney, Australia

*Michael J Sladden, Department of Medicine, University of Tasmania, Launceston General Hospital, Launceston, Tasmania, 7250, Australia. m.sladden@doctors.org.uk.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 7 OCT 2009

SEARCH

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Jeffrey M. Farma, Nandini Kulkarni, Cary Hsu, Surgical Management of Primary and Recurrent Melanoma, Surgical Oncology Clinics of North America, 2015, 24, 2, 239

    CrossRef

  2. 2
    Sandro Pasquali, Andrew Spillane, Contemporary controversies and perspectives in the staging and treatment of patients with lymph node metastasis from melanoma, especially with regards positive sentinel lymph node biopsy, Cancer Treatment Reviews, 2014, 40, 8, 893

    CrossRef

  3. 3
    Claudia Schulz, Hans-Martin Häfner, Helmut Breuninger, Ulrike Leiter, Local recurrence and survival in acral lentiginous melanoma comparing 3D histology and conventional histology, JDDG: Journal der Deutschen Dermatologischen Gesellschaft, 2014, 12, 10
  4. 4
    Claudia Schulz, Hans-Martin Häfner, Helmut Breuninger, Ulrike Leiter, Lokalrezidivraten und Überlebenswahrscheinlichkeit nach 3D-Histologie und konventioneller Histologie beim akrolentiginösen Melanom, JDDG: Journal der Deutschen Dermatologischen Gesellschaft, 2014, 12, 10
  5. 5
    Christopher English, Warren C. Hammert, Cutaneous Malignancies of the Upper Extremity, The Journal of Hand Surgery, 2012, 37, 2, 367

    CrossRef

  6. 6
    William Tuong, Lily S. Cheng, April W. Armstrong, Melanoma: Epidemiology, Diagnosis, Treatment, and Outcomes, Dermatologic Clinics, 2012, 30, 1, 113

    CrossRef

  7. 7
    Jonathan M. Olson, Murad Alam, Maryam M. Asgari, Needs Assessment for General Dermatologic Surgery, Dermatologic Clinics, 2012, 30, 1, 153

    CrossRef

  8. 8
    Felix C. Behan, Warren M. Rozen, Melissa M. Kwee, Shivam Kapila, Sian Fairbank, Michael W. Findlay, Oncologic clearance with preservation of reconstructive options: literature review and the ‘delayed reconstruction after pathology evaluation (DRAPE)’ technique, ANZ Journal of Surgery, 2012, 82, 11
  9. 9
    Steven M. Levine, Richard L. Shapiro, Surgical Treatment of Malignant Melanoma, Dermatologic Clinics, 2012, 30, 3, 487

    CrossRef

  10. 10
    S. Kruijff, H.J. Hoekstra, The current status of S-100B as a biomarker in melanoma, European Journal of Surgical Oncology (EJSO), 2012, 38, 4, 281

    CrossRef

  11. 11
    Peter Gillgren, Krzysztof T Drzewiecki, Marianne Niin, Hans P Gullestad, Henrik Hellborg, Eva Månsson-Brahme, Christian Ingvar, Ulrik Ringborg, 2-cm versus 4-cm surgical excision margins for primary cutaneous melanoma thicker than 2 mm: a randomised, multicentre trial, The Lancet, 2011, 378, 9803, 1635

    CrossRef

  12. 12
    Elisabeth Livingstone, Christine Windemuth-Kieselbach, Thomas K. Eigentler, Rainer Rompel, Uwe Trefzer, Dorothee Nashan, Sebastian Rotterdam, Selma Ugurel, Dirk Schadendorf, A first prospective population-based analysis investigating the actual practice of melanoma diagnosis, treatment and follow-up, European Journal of Cancer, 2011, 47, 13, 1977

    CrossRef

  13. 13
    Sandra C. Tomaszek, YeonSoo Kim, Stephen D. Cassivi, Matthew R. Jensen, Keh-Hsien R. Shen, Francis C. Nichols, Claude Deschamps, Dennis A. Wigle, Bronchial resection margin length and clinical outcome in non-small cell lung cancer, European Journal of Cardio-Thoracic Surgery, 2011,

    CrossRef

  14. 14
    Elizabeth A. O'Connor, William Dzwierzynski, Longitudinal Melonychia: Clinical Evaluation and Biopsy Technique, The Journal of Hand Surgery, 2011, 36, 11, 1852

    CrossRef

  15. 15
    Travis E. Grotz, Svetomir N. Markovic, Lori A. Erickson, William S. Harmsen, Marianne Huebner, David R. Farley, Barbara A. Pockaj, John H. Donohue, Franklin H. Sim, Clive S. Grant, Sanjay P. Bagaria, Thomas C. Shives, Charles M. Balch, James W. Jakub, Mayo Clinic Consensus Recommendations for the Depth of Excision in Primary Cutaneous Melanoma, Mayo Clinic Proceedings, 2011, 86, 6, 522

    CrossRef

  16. 16
    Richard A. Scolyer, Victor G. Prieto, Melanoma Pathology: Important Issues for Clinicians Involved in the Multidisciplinary Care of Melanoma Patients, Surgical Oncology Clinics of North America, 2011, 20, 1, 19

    CrossRef

  17. 17
    John F Thompson, David W Ollila, Optimum excision margins for melanoma, The Lancet, 2011, 378, 9803, 1608

    CrossRef

  18. 18
    F. Wright, K. Spithoff, A. Easson, C. Murray, J. Toye, D. McCready, T. Petrella, Primary Excision Margins and Sentinel Lymph Node Biopsy in Clinically Node-negative Melanoma of the Trunk or Extremities, Clinical Oncology, 2011, 23, 9, 572

    CrossRef

  19. 19
    Vincent Maida, Supportive Oncology, 2011,

    CrossRef

  20. 20
    J.R. Marsden, J.A. Newton-Bishop, L. Burrows, M. Cook, P.G. Corrie, N.H. Cox, M.E. Gore, P. Lorigan, R. MacKie, P. Nathan, H. Peach, B. Powell, C. Walker, Revised UK guidelines for the management of cutaneous melanoma 2010, Journal of Plastic, Reconstructive & Aesthetic Surgery, 2010, 63, 9, 1401

    CrossRef

  21. 21
    Chee-Chee H. Stucky, Richard J. Gray, Amylou C. Dueck, Nabil Wasif, Susan D. Laman, Aleksandar Sekulic, Barbara A. Pockaj, Risk factors associated with local and in-transit recurrence of cutaneous melanoma, The American Journal of Surgery, 2010, 200, 6, 770

    CrossRef

  22. 22
    Matthias Lechner, Chris Boshoff, Stephan Beck, Epigenetics and Cancer, Part A, 2010,

    CrossRef

  23. 23
    Patricia Louise Danielsen, In people with primary cutaneous melanoma, how do surgical excision margins affect outcomes?, Cochrane Clinical Answers,
  24. 24
    Simone Mocellin, Marko B Lens, Sandro Pasquali, Pierluigi Pilati, Vanna Chiarion Sileni, Interferon alpha for the adjuvant treatment of cutaneous melanoma, The Cochrane Library,
  25. 25
    Thrasivoulos Tzellos, Athanassios Kyrgidis, Simone Mocellin, An-Wen Chan, Pierluigi Pilati, Zoe Apalla, Interventions for melanoma in situ, including lentigo maligna, The Cochrane Library,
  26. 26
    Carlo Riccardo Rossi, Antonio Sommariva, Melanoma,
  27. 27
    Sandro Pasquali, Richard Kefford, Vanna Chiarion Sileni, Donato Nitti, Carlo Riccardo Rossi, Pierluigi Pilati, Simone Mocellin, Systemic treatments for metastatic cutaneous melanoma, The Cochrane Library,